Market Report: Shire backed as bid target after offer for ERT rival

Market Report: Shire backed as bid target after offer for ERT rival
Shortly after Sanofi-Aventis confirmed rumours of its .5bn bid for Genzyme, the market was looking at other potential pharma targets. One big UK-listed name in focus was Shire.
Read more on Independent